The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Low-Level Laser Stimulation on Hearing Thresholds

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01820416
Recruitment Status : Terminated (Analysis showed no clinically or statistically significant effects)
First Posted : March 28, 2013
Results First Posted : June 1, 2017
Last Update Posted : June 1, 2017
Sponsor:
Collaborator:
GN Resound
Information provided by (Responsible Party):
Shawn Goodman, University of Iowa

Study Type Interventional
Study Design Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Triple (Participant, Investigator, Outcomes Assessor);   Primary Purpose: Treatment
Condition Hearing Loss
Interventions Radiation: Low-level Laser Therapy
Other: Placebo Comparator: Disabled Laser
Enrollment 35
Recruitment Details  
Pre-assignment Details  
Arm/Group Title Low-Level Laser Therapy Disabled Laser Control
Hide Arm/Group Description

Low-level laser applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Low-level Laser Therapy: Portable unit containing two laser diodes producing 532 and 635 nm wavelengths. Both diodes produced energy levels of 7.5 mw (class IIIb). Beams from both diodes were dispersed through lenses to create parallel line-generated beams, rather than spots. The 532 nm light was constant, and the 635 nm light was pulsed, with frequencies of 15 and 33 Hz. The pulsing alternated between frequencies every 30 seconds.

Low-level laser device with laser diodes disabled. Also applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Placebo Comparator: Disabled Laser: Portable unit containing two DISABLED laser diodes. Same protocol was followed as for the Experimental (radiation) group, except that the disabled diodes produced no radiation.

Visit laboratory using same schedule as experiment and placebo. No Low-level laser or any treatment applied. Used to assess normal test-retest variability.
Period Title: Overall Study
Started 12 12 11
Completed 9 10 11
Not Completed 3 2 0
Arm/Group Title Low-Level Laser Therapy Disabled Laser Control Total
Hide Arm/Group Description

Low-level laser applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Low-level Laser Therapy: Portable unit containing two laser diodes producing 532 and 635 nm wavelengths. Both diodes produced energy levels of 7.5 mw (class IIIb). Beams from both diodes were dispersed through lenses to create parallel line-generated beams, rather than spots. The 532 nm light was constant, and the 635 nm light was pulsed, with frequencies of 15 and 33 Hz. The pulsing alternated between frequencies every 30 seconds.

Low-level laser device with laser diodes disabled. Also applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head. Visit laboratory using same schedule as experiment and placebo. No Low-level laser or any treatment applied. Used to assess normal test-retest variability. Total of all reporting groups
Overall Number of Baseline Participants 12 12 11 35
Hide Baseline Analysis Population Description
[Not Specified]
Age, Continuous  
Mean (Standard Deviation)
Unit of measure:  Years
Number Analyzed 12 participants 12 participants 11 participants 35 participants
51.33  (15.37) 55.58  (11.42) 47.09  (16.71) 51.46  (14.57)
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 12 participants 12 participants 11 participants 35 participants
Female
6
  50.0%
5
  41.7%
5
  45.5%
16
  45.7%
Male
6
  50.0%
7
  58.3%
6
  54.5%
19
  54.3%
Race and Ethnicity Not Collected   [1] 
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 0 participants 0 participants 0 participants 0 participants
0
[1]
Measure Analysis Population Description: Race and Ethnicity were not collected from any participant.
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
United States Number Analyzed 12 participants 12 participants 11 participants 35 participants
12 12 11 35
1.Primary Outcome
Title Change in Speech Perception
Hide Description Hearing status, as assessed by the Connected Sentence Test (CST). Difference scores (post-test - pretest) are reported. The CST approximates everyday conversation. Scoring is based on the number of correctly repeated key words. Higher numbers indicate better scores. The minimum score is 0 (0%) and the maximum is 100 (100%). When comparing test-retest scores for an individual, Cox et al. (1988) suggest that changes of 15% or more (based on 100 key words) are indicative of significant changes. We subtracted the post-test from the pre-test, so that negative difference scores indicate worse performance, and positive difference scores indicate better performance. Difference scores with an absolute value smaller than 15 are interpreted as no significant change. In addition, pre- and post-test performance was assessed for groups using t-tests on the difference scores.
Time Frame 7-10 days after baseline measures recorded
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Low-Level Laser Therapy Disabled Laser Control
Hide Arm/Group Description:

Low-level laser applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Low-level Laser Therapy: Portable unit containing two laser diodes producing 532 and 635 nm wavelengths. Both diodes produced energy levels of 7.5 mw (class IIIb). Beams from both diodes were dispersed through lenses to create parallel line-generated beams, rather than spots. The 532 nm light was constant, and the 635 nm light was pulsed, with frequencies of 15 and 33 Hz. The pulsing alternated between frequencies every 30 seconds.

Low-level laser device with laser diodes disabled. Also applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Placebo Comparator: Disabled Laser: Portable unit containing two DISABLED laser diodes. Same protocol was followed as for the Experimental (radiation) group, except that the disabled diodes produced no radiation.

Visit laboratory using same schedule as experiment and placebo. No Low-level laser or any treatment applied. Used to assess normal test-retest variability.
Overall Number of Participants Analyzed 9 10 11
Mean (Standard Deviation)
Unit of Measure: difference scores
-1.571  (6.949) 2.286  (8.46) -2.8  (5.329)
Time Frame Adverse event data were collected during the time that the study was being conducted (from 09/01/2009 to 12/31/2009).
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title Low-Level Laser Therapy Disabled Laser Control
Hide Arm/Group Description

Low-level laser applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Low-level Laser Therapy: Portable unit containing two laser diodes producing 532 and 635 nm wavelengths. Both diodes produced energy levels of 7.5 mw (class IIIb). Beams from both diodes were dispersed through lenses to create parallel line-generated beams, rather than spots. The 532 nm light was constant, and the 635 nm light was pulsed, with frequencies of 15 and 33 Hz. The pulsing alternated between frequencies every 30 seconds.

Low-level laser device with laser diodes disabled. Also applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head. Visit laboratory using same schedule as experiment and placebo. No Low-level laser or any treatment applied. Used to assess normal test-retest variability.
All-Cause Mortality
Low-Level Laser Therapy Disabled Laser Control
Affected / at Risk (%) Affected / at Risk (%) Affected / at Risk (%)
Total   --/--   --/--   --/-- 
Hide Serious Adverse Events
Low-Level Laser Therapy Disabled Laser Control
Affected / at Risk (%) Affected / at Risk (%) Affected / at Risk (%)
Total   0/12 (0.00%)   0/12 (0.00%)   0/11 (0.00%) 
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
Low-Level Laser Therapy Disabled Laser Control
Affected / at Risk (%) Affected / at Risk (%) Affected / at Risk (%)
Total   0/12 (0.00%)   0/12 (0.00%)   0/11 (0.00%) 
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Shawn S Goodman
Organization: Dept. of Communication Sciences & Disorders, University of Iowa
Phone: 319-335-8700
EMail: shawn-goodman@uiowa.edu
Layout table for additonal information
Responsible Party: Shawn Goodman, University of Iowa
ClinicalTrials.gov Identifier: NCT01820416    
Other Study ID Numbers: 200808718
First Submitted: March 25, 2013
First Posted: March 28, 2013
Results First Submitted: March 1, 2017
Results First Posted: June 1, 2017
Last Update Posted: June 1, 2017